Skip to main content

Stories by Coco Ballantyne

Is the mystery of the polo ponies solved?

The bizarre deaths of 21 polo ponies at last weekend's U.S. Open Polo Championship in Wellington, Fla., might have been caused by something in vitamin injections the horses received, the captain of the ponies' team has told reporters...

April 24, 2009 — Coco Ballantyne

Doctor attempts to clone people

A controversial fertility doctor today told British reporters that he has cloned 14 human embryos and transferred 11 of them into the uteruses of four women.

April 22, 2009 — Coco Ballantyne

Walnuts ward off breast cancer in mice

If you needed another reason to eat nuts, mice that eat an abundance of walnuts may be less likely to develop breast cancer, according to new study presented Tuesday at the meeting of the American Association for Cancer Research in Denver...

April 22, 2009 — Coco Ballantyne

Not all sugars are created equal

Sugar overload of any type does not bode well for your waistline or your health, but a new study suggests that certain sugars trigger more health problems than others.

April 20, 2009 — Coco Ballantyne

Urine test predicts smokers' lung cancer risk

Quick to light up despite the potential risks? Take note: there may be a way to rapidly predict your chances of developing lung cancer – and provide yet more incentive to kick the habit...

April 20, 2009 — Coco Ballantyne

New technique reveals far more silent heart attacks

Take heart: there's a new way to detect whether someone has suffered a so-called silent heart attack, one in which vessels to the ticker become blocked but there are few of the typical telltale signs such as chest pain...

April 17, 2009 — Coco Ballantyne

Using GPS to track down asthma triggers

Global positioning system (GPS) devices are everywhere these days—in cars, cell phones, dog collars—and now, even in asthma inhalers. Researchers from the University of Wisconsin–Madison recently launched a study using GPS devices to monitor where and when patients use their inhalers, a technology they hope will uncover unrecognized triggers of asthma symptoms...

April 17, 2009 — Coco Ballantyne

The JAMA saga continues

Two weeks ago, we posted a blog about a case involving a researcher who failed to report ties to the maker of a drug he favorably reviewed in JAMA The Journal of the American Medical Association ...

April 15, 2009 — Coco Ballantyne

Statins do not protect against dementia

Cholesterol-busting statins may lower the odds of suffering from a heart attack or stroke, but they don't appear to ward off dementia as researchers had hoped, a new review of clinical trials suggests...

April 14, 2009 — Coco Ballantyne

A new type of painkiller

A new extended-release anesthetic can safely numb body parts for as long as a week, a new study in rats suggests. If the anesthetic has the same effect in humans, it might one day be used to manage chronic and surgery-induced pain, researchers say...

April 14, 2009 — Coco Ballantyne

Battling bioterror--A new test for ricin

Scientists say they have developed a fast and supersensitive new test for ricin, a poison found in castor beans that scientists say is a prime candidate for use in bioterrorism attacks.

April 13, 2009 — Coco Ballantyne

New chemicals for ecofriendly paints and lubricants

Last week, reported on the resurrection of olestra—a chemical once touted as the great fat alt in chips and crackers that tumbled when it turned out that it triggered gastrointestinal problems in those who chomped products containing it...

April 13, 2009 — Coco Ballantyne
Slide Show: Rabbits at Risk

Slide Show: Rabbits at Risk

What better time than Easter to familiarize yourself with rabbits in danger of extinction

April 10, 2009 — Coco Ballantyne

Adults store calorie-burning brown fat

A new study confirms that calorie-burning tissue called brown fat once believed to be present only in infants is actually relatively common in adults – at least in slender ones.

April 9, 2009 — Coco Ballantyne

HIV drugs turned street drugs in South Africa

Teens in South Africa have found a new use for efavirenz (brand name Stocrin in South Africa and Sustiva in the U.S.), an antiretroviral drug that prevents HIV from making copies of itself in the body...

April 7, 2009 — Coco Ballantyne
Scroll To Top